重复的早期怀孕损失和先天性血栓友病:一项前性研究
Asma Basha1,2, Yasmine Alkhatib2, Tamara Tashtoush2
1Department of Obstetrics and Gynecology, School of Medicine, The University of Jordan, Amman 11942, Jordan.
Journal of clinical medicine
|November 27, 2024
概括
先天性血栓性突变,特别是MTHFR和XIII Val34Leu因子,在年轻女性早期重复性妊娠丧失 (RPL) 中发挥着重要作用. 某些基因变异,如EPCR A2/A2,提供对RPL的保护作用.
科学领域:
- 遗传学 是一个遗传学.
- 生殖医学 生殖医学
- 血液学 血液学 血液学
背景情况:
- 复发性流产 (RPL) 影响年轻女性,先天性血栓形成是潜在的促成因素.
- 对于了解早期的RPL而言,研究血栓友的特定遗传突变至关重要.
- 已获得的RPL原因被排除在外,以关注遗传性遗传倾向.
研究的目的:
- 为了调查先天性单核酸血栓性在年轻女性经历早期RPL.的作用.
- 确定与早期RPL增加风险或保护作用相关的特定遗传突变.
- 分析中东人口中血栓友突变的流行率与RPL.
主要方法:
- 一项病例控制研究,涉及120名RPL女性和80名对照.
- 对与血栓相关的单核酸多态的遗传分析,包括MTHFR,V因子Leiden,因子II G20210A,FXIII,PAI-1和EPCR.
- 进行了凝血测试和检测抗β2-糖蛋白I抗体.
主要成果:
- MTHFR C677T,MTHFR A1298C,异构性FXIII Val34Leu和异构性FXIII 1694 C>T突变与早期RPL有显著的关联.
- 内皮蛋白C受体 (EPCR) A2/A2,野生FXIII Val34Leu和异构体FXIII 1694 C>T显示出具有统计学意义的保护作用.
- 特定的先天性血栓性突变对早期重复妊娠流产的风险产生显著影响.
结论:
- 在早期RPL的中东年轻女性中,先天单核酸血栓性突变很重要.
- 在这个人群中,MTHFR突变和FXIII Val34Leu特别重要.
- EPCR A2/A2,野生FXIII Val34Leu和异合体FXIII 1694 C>T具有保护作用,需要进一步研究.
关键词:
在EPCR中,EPCR是EPCR.在FXIII中,我们可以看到FXIII.在MTHFR的基础上.PAI-1是PAI-1的第一个类型.在这个过程中,PTPTPTPT在PTTTT中,我们可以看到PTT.经常发生的怀孕流产.血栓友爱症 (Thrombophilia) 是一种发生血栓友爱的疾病.更多相关视频
09:52Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
Published on: September 5, 2011
26.8K
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
1.2K
相关概念视频
01:24Disorders of Hemostasis
710
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
710
01:07Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K